Answers are grounded in this paper and cite their sources.
Introduction: Management of type 2 diabetes is based on achieving the glycaemic control goal with the help of drugs or insulin. There are many markers used to measure glycaemic control, such as glycated haemoglobin (HbA1c), random blood sugar and fructosamine levels. Although HbA1c is a good method for measuring glycaemic control, it has some limitations. Fructosamine is a less studied method that can be used as another marker to measure glycaemic control when HbA1c is questionable or absent. The aim of this study was to evaluate the use of fructosamine as an alternate marker for glycaemic control by comparing fructosamine levels with HbA1c in glycaemic control in type 2 diabetic patients. Materials and Methods: This is a cross-sectional study involving 77 patients with type 2 diabetes from the central laboratory of Bowring and Lady Curzon Hospital, Shivajinagar, Bangalore. Data collected includes age, gender, body mass index, diabetes duration, fructosamine, HbA1c and fasting blood sugar (FBS) levels. Glycaemic control level is measured by HbA1c, fructosamine and FBS. Results: Analysis of glycaemic control in 77 patients with type 2 diabetes showed a positive association between fructosamine and HbA1c levels (P < 0.001). Conclusion: Fructosamine levels are significantly associated with HbA1c levels, so fructosamine can be used as a biomarker to assess glycaemic control in patients with type 2 diabetes, especially when HbA1c is significantly erroneous or absent.
No takes yet. Share an insight, caveat, or question.
Naik et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: